HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N3-o-toluyl-fluorouracil

atofluding derivative that Inhibits human gastric carcinoma cell growth; structure in first source

Also Known As:

N3-o-toluyl-5-fluorouracil

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidinones: 71
      - Uracil: 1493
        Fluorouracil: 26711
        N3-o-toluyl-fluorouracil: 3

Experts

1.	Feng, Lixia: 1 article (05/2013)
2.	Li, Min: 1 article (05/2013)
3.	Zhang, Juan: 1 article (05/2013)
4.	Zhang, Li: 1 article (05/2013)
5.	Zhang, Na: 1 article (05/2013)
6.	Chen, Ming-Hui: 1 article (11/2006)
7.	Cui, Shu-Xiang: 1 article (11/2006)
8.	Gai, Ruo-Yan: 1 article (11/2006)
9.	Liu, Jian: 1 article (11/2006)
10.	Makuuchi, Masatoshi: 1 article (11/2006)

Related Diseases

1.	Carcinoma (Carcinomatosis) 11/14/2006 - "To evaluate the growth inhibition efficacy of atofluding derivative N3-o-toluyl-fluorouracil (TFU) on human gastric carcinoma cell lines SGC-7901 and MKN-45. " 11/14/2006 - "Inhibition of human gastric carcinoma cell growth by atofluding derivative N3-o-toluyl-fluorouracil."
2.	Neoplasms (Cancer) 05/01/2013 - "The in vitro anti-tumor efficacy and the pharmacokinetics of N3-o-toluyl-fluorouracil loaded nanosuspension (TFu-LNS)." 12/01/1980 - "Several N3-benzoyl- and N3-o-toluyl-5-fluorouracil derivates and showed significant activity against experimental tumor, and N1-acetyl-N3-o-toluyl-5-fluorouracil was found to be most promising among them. "

Related Drugs and Biologics

1.	atofluding